The new $56000 Alzheimer’s Drug Alduhelm Might Actually Be Costlier; Experts Look For Answers
The new drug Alduhelm manufactured by Biogen has recently gained approval from the Food and Drug Administration (FDA) for usage in the USA However, the high price of the drug, $56,000, has already sparked significant controversies as its effectiveness is not yet been proved in slowing down the deterioration of the brain and cognitive function…